JAN 21, 2020 6:42 PM PST

A gene for leukemia triggers the growth of stem blood cells

New research from the University of Colorado Cancer Center has identified a way to make hematopoietic stem cells from a gene that causes a type of leukemia in children. The work was led by Patricia Ernst, Ph.D., CU Cancer Center investigator and professor in the CU School of Medicine Departments of Pediatrics, and was published recently in the journal Stem Cell Reports.

In fact, the discovery about hematopoietic stem cells (HSCs) came as quite a surprise for Ernst and her colleagues. She comments:

"My lab was working on a gene called MLL that, when accidentally fused together with another gene, causes childhood leukemia," says Ernst. "Half my lab was studying MLL's role in leukemia and the other half was exploring what MLL normally does," Ernst says. "When we knocked out this gene, we saw that hematopoietic stem cells couldn't retain their 'stemness' -- instead of being HSCs, they would differentiate to become like normal cells of the blood system. So, we wondered what would happen if we increased it," Ernst says.

This observation led the team of researchers to analyze the function of MLL down to the cellular level. They concluded two key findings regarding the role the gene plays in stem cell differentiation and maintenance. First, they determined that increasing the amount of MLL protein in pluripotent stem cells triggers the cells to generate more blood cells, which has significant implications for leukemia patients recovering from chemotherapy and irradiation.

"As pluripotent cells differentiate, they enter a kind of transitional state in which they still have the potential to become many different cell types. Single-cell sequencing let us watch the fate of these transitional cells, and we saw that activating MLL led to more of these transitional cells becoming blood cell types," Ernst says.

Second, the team discovered that the MLL gene and its cancer-causing cousin can be targeted individually, which could improve drug development against MLL-rearranged childhood leukemia. "It's about selective targeting," Ernst says. "We want to selectively turn off the cancer-causing MLL fusion gene without affecting the regular form of the MLL gene."

Photo: Pixabay

Ernst and her colleagues aim to continue their investigations in order to develop a drug-based method to augment MLL levels. The goal is to "make customizable stem cell products that could be adapted to any particular patient," Ernst says.

Sources: Stem Cell Reports, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 23, 2021
Cancer
A Safe and Effective Combination Therapy for Advanced Cancer
AUG 23, 2021
A Safe and Effective Combination Therapy for Advanced Cancer
Immunotherapies are emerging as a promising strategy for the treatment of late-stage cancers which currently have m ...
SEP 27, 2021
Cell & Molecular Biology
Optical Imaging in Tissue with Near-Infrared Dyes
SEP 27, 2021
Optical Imaging in Tissue with Near-Infrared Dyes
Optical Imaging in Tissue with Near-Infrared Dyes Written By Christopher Pratt, PhD   Go Long to See Deeper Imaging ...
OCT 07, 2021
Cancer
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
OCT 07, 2021
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
Neuroblastoma is a cancer of immature nerve cells found in various areas, including the adrenal glands, neck, chest ...
OCT 11, 2021
Cancer
Different Cancer Types Metastasize to Specific Regions of the Brain
OCT 11, 2021
Different Cancer Types Metastasize to Specific Regions of the Brain
Metastatic cancer occurs when cancer spreads from its original site of origin to a distant location in the body. Wh ...
OCT 28, 2021
Cancer
NF-κB: a Trick or a Treat for Cancer?
OCT 28, 2021
NF-κB: a Trick or a Treat for Cancer?
A family of proteins, known as transcription factors, regulate the biological process of converting DNA into RNA. T ...
DEC 18, 2021
Cell & Molecular Biology
How the HTLV-1 Virus Can Turn Immune Cells Cancerous
DEC 18, 2021
How the HTLV-1 Virus Can Turn Immune Cells Cancerous
In some cases, viruses have been linked to cancer. For example, HPV, which is now preventable with a vaccine, can lead t ...
Loading Comments...